Atlas Trials

8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C

Clinical trial NCT04885855 · COMPLETED

Trial details

NCT number
NCT04885855
Sponsor
Muhammad Radzi Abu Hassan
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2021-03-23
Primary completion
2023-12-29
Enrollment
322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.